These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4286128)

  • 21. [Lipase activities in the cerebrospinal fluid].
    Kluge H; Wieczorek V
    Psychiatr Neurol Med Psychol (Leipz); 1968 Sep; 20(9):340-2. PubMed ID: 5731889
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of cholinesterase with Acholest (paper test). Diagnostic possibilities in internal medicine].
    Ningerová B; Pojer J; Cernochová Z
    Vnitr Lek; 1969 Aug; 15(8):779-83. PubMed ID: 5810001
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum cholinesterase deficiency. I. Disease and inheritance.
    Robertson GS
    Br J Anaesth; 1966 May; 38(5):355-60. PubMed ID: 5328263
    [No Abstract]   [Full Text] [Related]  

  • 24. [ACTH in the treatment of multiple sclerosis].
    Palazzoli A; De Lorenzi L; Paiardi A
    Boll Soc Med Chir Cremona; 1967; 21(3):147-60. PubMed ID: 4299611
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
    Raine CS; Wu E; Ivanyi J; Katz D; Brosnan CF
    Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACTH-induced cortisol production in multiple sclerosis.
    Snyder BD; Lakatua DJ; Doe RP
    Ann Neurol; 1981 Oct; 10(4):388-9. PubMed ID: 6274253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R
    J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital].
    Schanke AK; Grimsmo J; Sundet K
    Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1349-52. PubMed ID: 7770829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Testing of the activity of serum cholinesterase in patients with liver disease with the aid of the cholinesterase test-paper "Acholest"].
    Golubeva NA
    Ter Arkh; 1966 May; 38(5):72-5. PubMed ID: 5991933
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of the determination of whole blood cholinesterase activity in patients with peptic ulcer].
    Proschenko NL
    Vrach Delo; 1965 Jun; 6():57-9. PubMed ID: 5856588
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of multiple sclerosis. II. Serial neurologic examinations and use of corticotropin and glucocorticoids.
    McFarland HR
    Mo Med; 1969 Feb; 66(2):113-6. PubMed ID: 4302927
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple sclerosis and other related inflammatory disorders of the central nervous system: differential diagnosis and treatment.
    Lyon-Caen O; Fontaine B; Gout O; Tourbah A
    Acta Neurol Belg; 1994; 94(2):92-7. PubMed ID: 8036882
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enzymes in human bile. II. Enzyme content of liver- and gallbladder bile].
    Lorentz K; Niemann E; Jaspers G; Oltmanns D
    Enzymol Biol Clin (Basel); 1969; 10(6):528-33. PubMed ID: 5307939
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in biochemical components of extracellular matrix in intervertebral disc herniation: role of MMP-2 and TIMP-2 in type II collagen loss.
    Kozaci LD; Guner A; Oktay G; Guner G
    Cell Biochem Funct; 2006; 24(5):431-6. PubMed ID: 16142692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metallothionein expression in the central nervous system of multiple sclerosis patients.
    Penkowa M; Espejo C; Ortega-Aznar A; Hidalgo J; Montalban X; Martínez Cáceres EM
    Cell Mol Life Sci; 2003 Jun; 60(6):1258-66. PubMed ID: 12861391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on the seasonal incidence of multiple sclerosis. II. The seasonal variability of biological data].
    Rieder HP; Wüthrich R; Ritzel G
    Schweiz Arch Neurol Neurochir Psychiatr; 1968; 101(2):282-92. PubMed ID: 5710164
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis.
    Gold SM; Raji A; Huitinga I; Wiedemann K; Schulz KH; Heesen C
    J Neuroimmunol; 2005 Aug; 165(1-2):186-91. PubMed ID: 15935481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive therapy in neurological diseases.
    Cendrowski W; Riekkinen PJ; Rinne UK
    Ann Clin Res; 1974 Dec; 6(6):323-9. PubMed ID: 4375431
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunology of multiple sclerosis].
    Mussini JM
    Sem Hop; 1982 Dec; 58(45):2676-9. PubMed ID: 6297066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Examination of the changes in the cholinesterase level of the blood during surgery using "Acholest". (Data on the problem of anesthetic hazards)].
    Aranyosi J; Bacsa S
    Orv Hetil; 1966 Aug; 107(33):1553-5. PubMed ID: 5945673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.